id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-P-7376-0008,FDA,FDA-2025-P-7376,Completeness Assessment Correspondence,Other,Assessment Document or Analysis,2026-02-10T05:00:00Z,2026,2,2026-02-10T05:00:00Z,,2026-02-11T00:17:09Z,,0,0,09000064b919f2bb
FDA-2025-P-7376-0007,FDA,FDA-2025-P-7376,"Amendment from WhiteOak Group, LLC",Other,Ammendment,2026-01-27T05:00:00Z,2026,1,,,2026-02-02T21:09:43Z,,0,0,09000064b91858a8